Open AccessFixed-dose capecitabine is feasible: results from a pharmacokinetic and pharmacogenetic study in metastatic breast cancer
Author(s) -
Michelle A. Rudek,
Roisín M. Connolly,
Janelle M. Hoskins,
Elizabeth GarrettMayer,
Stacie C. Jeter,
Deborah K. Armstrong,
John H. Fetting,
Vered Stearns,
Laurie A. Wright,
Ming Zhao,
Susan Cotts Watkins,
Howard L. McLeod,
Nancy E. Davidson,
Antonio C. Wolff
Publication year - 2013
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/7ceh-c266
Subject(s) - capecitabine , pharmacogenetics , metastatic breast cancer , medicine , pharmacokinetics , breast cancer , oncology , pharmacology , cancer , colorectal cancer , genotype , chemistry , biochemistry , gene